80-90 children annually diagnosed with cancer in Armenia

10:08 • 15.02.13

Every year, around 80-90 children in Armenia are diagnosed with cancer, the rate remaining unchanged for the past 10-12 years.


Some 65%-70 of the cases, including malignant tumors, are cured.


The cancer statistics is 85%-90% in the developed world and 20%-30% in the developing countries, says Professor Grigor Badalyan, the head of the Child Oncology Department at the Fanarjyan National Oncological Center.


According to him, malignant tumors in children differ from adult cancer in structure, form of treatment and outcome.


“Child cancer, with all its pathologies taken together, is subject to a better treatment, with the majority of the children – 65%-70% - being cured,” the doctor told Tert.am, presenting the child cancer statistics and treatment methods on the occasion of the International Childhood Cancer Day.


After a complex treatment lasting about a year, the child remains under doctors’ observation to avoid the risk of the disease recurrence. This period for adults is five years as opposed to children who are required to remain under post-treatment observation for only two years.


In case the tumor does not recur in two years, the child is considered cured provided that he or she undergoes a medical checkup once per year.


“The disease recurs very rarely,” Badalyan noted.


A major part of the treatment– about 80% - falls to chemotherapy, given that children are tolerant to this form of treatment. Radiation and surgical intervention are less frequently applied, but they are resorted to in case of being recommended.


Asked whether the children with cancer have any idea of their disease, the specialist said that the very young patients have no idea at all unlike the older ones who often realize what they suffer from.


“The older children do realize the seriousness of the disease even if they do not have a full idea,” he added.


The most widespread form of child cancer is leukemia which makes up 22%-25% of the total number of the cases. Lymphomas, with 18%-20%, are the second in frequency. Malignant brain tumors, bone and kidney cancer come next.


As for the Armenian Bone Morrow Donor Registry, the Professor said that it is very important that Armenia has such a center. In the meantime, he unveiled plans for introducing the peripheral stem cell transplantation method in the near future.